Autopsy report · NCT00914043

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

“Withdrawn as NCI rescinded approval for parent study NSABP-B-45”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

NSABP Foundation Inc

Sponsor type

University, hospital or other

Conditions

Breast Cancer; Fatigue

Interventions

gene expression analysis; microarray analysis; polymerase chain reaction; polymorphism analysis; reverse transcriptase-polymerase chain reaction; biologic sample preservation procedure

Participants

0

Trials that died the same way

• Antibiotics and Tissue Expanders in Breast Reconstruction
  “The study was withdrawn prior to IRB approval.” (67% match in meaning)
• Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study
  “Study never initiated; withdrawn prior to receiving IRB approval” (66% match in meaning)
• A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck
  “After loss of orphan drug status in Korea, study was withdrawn due to Regulatory Authority request. Patients will be enrolled into NCT01075828 instead.” (64% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (63% match in meaning)
• Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients
  “The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved. No participants were enrolled.” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.